Circular Protocol Partners with Arculus and IT Lab to Enhance Digital Security in Healthcare Using Blockchain Technology

Circular Protocol partners with Arculus and IT Lab to enhance digital security and transparency in healthcare using blockchain technology.

Quiver AI Summary

Circular Protocol has announced a partnership with Arculus by CompoSecure and IT Lab to enhance digital transparency and security in the healthcare sector. This collaboration will introduce a solution that leverages the Circular blockchain to authenticate and verify patient records, facilitating secure management of healthcare data. The integration of Arculus Authentication into Circular's MedTech device will allow healthcare personnel to use a physical card that securely signs off on medical procedures through a simple tap, ensuring data privacy and preventing fraud. The initiative aims to create a decentralized and transparent healthcare system, starting with the recording of exams in over 8,000 pharmacies in Italy and plans to launch in the U.S. market by Q2 2025. The goal is to empower healthcare providers and patients while maintaining streamlined access to medical information and protecting patient rights.

Potential Positives

• Announcement of a strategic partnership with CompoSecure and IT Lab enhances Circular Protocol's credibility and presence in the healthcare sector.
• Introduction of a secure blockchain solution for managing healthcare data reinforces the company's commitment to digital transparency and patient privacy.
• Expected rollout in Q2 2025 signifies timely entry into a market that is increasingly demanding secure and efficient healthcare solutions.
• Potential to revolutionize the healthcare system with decentralized technology that empowers both providers and patients through enhanced data ownership and security.

Potential Negatives

• Partnership with IT Lab is limited to Italy, which may restrict the initial impact and scalability of the initiative.
• Press release does not provide concrete metrics or data to support claims of improved data security and transparency, potentially leading to skepticism about the initiative's efficacy.
• The rollout is not scheduled until Q2 2025, suggesting delays in implementation and potential missed opportunities in the rapidly evolving healthcare technology sector.

FAQ

What is the new initiative announced by Circular Protocol?

Circular Protocol announced a commercial initiative with Arculus by CompoSecure and IT Lab to enhance digital transparency in healthcare.

How will the partnership improve healthcare data security?

The partnership will integrate blockchain technology for secure verification and authentication of medical records, enhancing patient privacy.

What technology is being used for this healthcare initiative?

The initiative employs Circular's blockchain and Arculus Authentication to securely manage and protect healthcare data using a physical card.

When is the expected launch of the new healthcare system?

The new decentralized healthcare system is expected to launch in the U.S. market in Q2 2025.

Who are the key partners involved in this healthcare initiative?

The key partners are Circular Protocol, Arculus by CompoSecure, and IT Lab, specializing in healthcare software solutions.

Disclaimer: This is an AI-generated summary of a press release distributed by GlobeNewswire. The model used to summarize this release may make mistakes. See the full release here.

$CMPO Congressional Stock Trading

Members of Congress have traded $CMPO stock 2 times in the past 6 months. Of those trades, 2 have been purchases and 0 have been sales.

Here’s a breakdown of recent trading of $CMPO stock by members of Congress over the last 6 months:

• REPRESENTATIVE BRAD KNOTT has traded it 2 times. They made 2 purchases worth up to $30,000 on 01/14, 01/10 and 0 sales.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

$CMPO Insider Trading Activity

$CMPO insiders have traded $CMPO stock on the open market 24 times in the past 6 months. Of those trades, 13 have been purchases and 11 have been sales.

Here’s a breakdown of recent trading of $CMPO stock by insiders over the last 6 months:

• THOMAS R. KNOTT has made 4 purchases buying 879,963 shares for an estimated $13,848,119 and 0 sales.
• JOHN D. COTE has made 4 purchases buying 879,963 shares for an estimated $13,848,119 and 0 sales.
• COMPO HOLDINGS LLC RESOLUTE has made 4 purchases buying 879,963 shares for an estimated $13,848,119 and 0 sales.
• ADAM JOSEPH LOWE (Chief Product & Innov. Officer) has made 0 purchases and 5 sales selling 124,478 shares for an estimated $1,874,474.
• GREGOIRE MAES (Chief Operating Officer) has made 0 purchases and 3 sales selling 80,000 shares for an estimated $1,308,243.
• JOSEPH J DEANGELO purchased 45,045 shares for an estimated $500,900
• AMANDA MANDY GOURBAULT (Chief Revenue Officer) has made 0 purchases and 3 sales selling 10,622 shares for an estimated $170,817.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

$CMPO Hedge Fund Activity

We have seen 112 institutional investors add shares of $CMPO stock to their portfolio, and 68 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• UBS GROUP AG added 4,549,703 shares (+5723.7%) to their portfolio in Q4 2024, for an estimated $69,746,946
• CAPITAL WORLD INVESTORS added 1,786,525 shares (+inf%) to their portfolio in Q4 2024, for an estimated $27,387,428
• DIVISADERO STREET CAPITAL MANAGEMENT, LP added 1,048,566 shares (+inf%) to their portfolio in Q4 2024, for an estimated $16,074,516
• NINE TEN CAPITAL MANAGEMENT LLC added 908,328 shares (+inf%) to their portfolio in Q4 2024, for an estimated $13,924,668
• WESTERN STANDARD LLC removed 828,073 shares (-100.0%) from their portfolio in Q3 2024, for an estimated $11,609,583
• LOCUST WOOD CAPITAL ADVISERS, LLC added 734,202 shares (+19.1%) to their portfolio in Q4 2024, for an estimated $11,255,316
• ZUCKERMAN INVESTMENT GROUP, LLC added 700,858 shares (+85.0%) to their portfolio in Q4 2024, for an estimated $10,744,153

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

$CMPO Analyst Ratings

Wall Street analysts have issued reports on $CMPO in the last several months. We have seen 2 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

• Cowen & Co. issued a "Buy" rating on 12/18/2024
• Lake Street issued a "Buy" rating on 10/02/2024

To track analyst ratings and price targets for $CMPO, check out Quiver Quantitative's $CMPO forecast page.

$CMPO Price Targets

Multiple analysts have issued price targets for $CMPO recently. We have seen 2 analysts offer price targets for $CMPO in the last 6 months, with a median target of $19.0.

Here are some recent targets:

• An analyst from Lake Street set a target price of $15.0 on 03/06/2025
• Steve Moss from B.Riley Financial set a target price of $23.0 on 11/11/2024

Full Release

BOSTON, Mass, and SOMERSET, N.J., March 20, 2025 (GLOBE NEWSWIRE) --


Circular Protocol


today announced a new commercial initiative with two leaders in the security and software space, Arculus by CompoSecure, and IT Lab to step up digital transparency and protection in the global healthcare industry.

As healthcare becomes increasingly digital and interconnected, verification and authentication of patient records and healthcare data are essential for ensuring data accuracy, protecting patient privacy, and preventing fraud.

Today’s announcement delivers an advanced solution that will integrate into clinical networks and serve as the secure passkey for recording, managing, and safeguarding critical healthcare data within facilities using the MedTech device.

The Circular blockchain is building the first digital network for on-chain verification and authentication of medical records and transactions. Integrating Arculus Authentication, by CompoSecure, into the company’s MedTech device, healthcare providers will create a physical card (which holds a private key) for hospitals and healthcare centers, to allow authorized administrators, operators, and patients to digitally sign off procedures, exams and other transactions, directly on the Circular blockchain, simply by tapping the card to their computer. The card can be used in clinical networks, as the key to record, own and protect all data regarding programs and activities of the facilities utilizing the MedTech device.

“Tech needs to be invisible and easy to use while delivering the benefits of secure and immutable records on a public registry, so the rights of medical institutions and patients are protected, and their data safely stored,” said Dr. Gianluca De Novi, Founder and CEO at Circular Protocol.

“We are excited about this partnership and where blockchain and healthcare converge to set a new standard for data protection,” said Dr. Adam Lowe, Chief Product Officer at CompoSecure. “This is an exciting future where patients have true ownership and seamless and secure access to their medical information.”

Circular is also partnering with IT Lab, an Italian software powerhouse specialized in the healthcare sector. More than 8,000 pharmacies in Italy will record on-chain the exams they are allowed to perform on-premises, becoming safe and transparent providers of medical procedures. The recording takes place via their ‘Smart Share’ white label platform, already available in all pharmacies running the proof-of-concept (POC) for the first few months, with no need to own cryptocurrencies or a wallet. The rollout is expected in Q2 2025. The launch is designed to be the first truly decentralized, secure and transparent healthcare system of its kind. Costs are the same as a standard clinical exam, but with the added value of proximity, and all the blockchain-generated benefits.

“We are evolving healthcare towards a future where each touchpoint is monitored and where the burden of exams and treatments will be redistributed and performed where it makes the most sense, from a cost, proximity and competence perspective, empowering pharmacies, as well as hospitals, in full transparency and security for operators and patients”, said Anthony D’Angelo, CEO of ITLab “This will all be accessible via the current interfaces, but certifying patient data becomes, for the first time, the key for tremendous value for the whole healthcare and medical network, and Circular is leading this transformation.”

This ecosystem is expected to launch in the U.S. market in Q2 2025, providing healthcare institutions with seamless blockchain integration. To learn more, visit:

https://www.circularprotocol.org

About Circular Protocol.



Circular is a 4th-generation Layer 1 blockchain, designed to address the limitations of previous generation Layer 1 chains. Circular’s primary focus is DeSci and Healthcare, where developers and enterprises can advance research, innovation, and in-market execution across healthcare, pharma, and scientific industries, promoting transparency, data security, and democratized access and ownership. Circular Protocol provides tamper-proof data auditing via decentralized blockchains and zero-knowledge proofs, ensuring compliance, protecting patient data, and certifying processes and content. With privacy, decentralization, maximum throughput, scalability, interoperability, and proof of reputation, Circular’s proprietary parallelized, multi-chain architecture delivers revolutionary tools and applications.

Circular has offices in Boston and Lugano. Its CEO and Founder, Dr. Gianluca De Novi, is an expert in high-performance computing with a background in 3D real-time graphics, physics simulation, robotics, and blockchain technology. He holds a Master’s in Electronics and Computer Science and a PhD in Robotics from the University of Bologna. Currently, he directs the Medical Device and Simulation Lab at Massachusetts General Brigham and is a faculty member at Harvard Medical School and Harvard Extension School since 2011. His work includes approximately 15 years of research funded by the US Department of Defense in the MedTech industry.

About CompoSecure



Founded in 2000, CompoSecure (Nasdaq: CMPO) is a technology partner to market leaders, fintechs and consumers enabling trust for millions of people around the globe. The company combines elegance, simplicity and security to deliver exceptional experiences and peace of mind in the physical and digital world. CompoSecure’s innovative payment card technology and metal cards with Arculus security and authentication capabilities deliver unique, premium branded experiences, enable people to access and use their financial and digital assets and ensure trust at the point of a transaction. For more information, please visit

www.CompoSecure.com

and

www.GetArculus.com

.

Corporate Contact


Anthony Piniella


Head of Communications, CompoSecure


(917) 208-7724


apiniella@composecure.com

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.